BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

VOR

Vor Biopharma Inc.
Nasdaq · Biological products, (no diagnostic substances) (SIC 2836) · FY ends 31 Dec

Revenue, quarterly

—
Not reported in this company’s filings
Company filingsvpside.com

Gross margin, trailing twelve months

—
Not reported in this company’s filings
Company filingsvpside.com

Cash and cash equivalents, quarter-end

$79M−50.8% year on year
$400M$200M$0
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 30 Oct 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$120M
$100M$0−$100M−$200M
Q4 ’21Q1 ’23Q2 ’24Q2 ’25Q3 ’26
Company filings · 10-Q filed 30 Oct 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty